Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


CASAMENTO CHARLES J Create: Alert

All | News | Filings
Date FiledTypeDescription
10/04/2023 4 CASAMENTO CHARLES J (Director) has filed a Form 4 on PaxMedica, Inc.
Txns: Paid exercise price by delivering 6,536 shares @ $0.2861, valued at $1.9k
05/30/2023 4 CASAMENTO CHARLES J (Director) has filed a Form 4 on RELMADA THERAPEUTICS, INC.
Txns: Granted 92,958 options to buy @ $3.37, valued at $313.3k
05/04/2023 3 CASAMENTO CHARLES J (Director) has filed a Form 3 on GT Biopharma, Inc.
04/14/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/05/2023 4 CASAMENTO CHARLES J (Director) has filed a Form 4 on First Wave BioPharma, Inc.
Txns: Granted 84,745 shares @ $0
12/20/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/04/2022 4 CASAMENTO CHARLES J (Director) has filed a Form 4 on PaxMedica, Inc.
Txns: Granted 51,583 shares @ $0
10/04/2022 3 CASAMENTO CHARLES J (Director) has filed a Form 3 on PaxMedica, Inc.
05/26/2022 4 CASAMENTO CHARLES J (Director) has filed a Form 4 on RELMADA THERAPEUTICS, INC.
Txns: Granted 91,235 options to buy @ $19.03, valued at $1.7M
04/05/2022 4 CASAMENTO CHARLES J (Director) has filed a Form 4 on RELMADA THERAPEUTICS, INC.
Txns: Sold 3,300 shares @ $29, valued at $95.7k
Exercised 19,800 options to buy @ $3.24, valued at $64.2k
02/28/2022 4 CASAMENTO CHARLES J (Director) has filed a Form 4 on Eton Pharmaceuticals, Inc.
Txns: Granted 50,000 options to buy @ $3.78, valued at $189k
01/03/2022 4 CASAMENTO CHARLES J (Director) has filed a Form 4 on First Wave BioPharma, Inc.
Txns: Granted 34,482 options to buy @ $1.45, valued at $50k
09/24/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/19/2021 4 CASAMENTO CHARLES J (Director) has filed a Form 4 on RELMADA THERAPEUTICS, INC.
Txns: Exercised 10,000 options to buy @ $4.6, valued at $46k
07/16/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/22/2021 4/A Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
06/02/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/05/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/05/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/05/2021 4 CASAMENTO CHARLES J (Director) has filed a Form 4 on RELMADA THERAPEUTICS, INC.
Txns: Sold 1,309 shares @ $35.9265, valued at $47k
Sold 1,691 shares @ $35.0403, valued at $59.3k
03/02/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/02/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/11/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/06/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/05/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/02/2020 4 CASAMENTO CHARLES J (Director) has filed a Form 4 on RELMADA THERAPEUTICS, INC.
Txns: Gifted 21,223 shares @ $0
Sold 3,000 shares @ $35.7397, valued at $107.2k
11/03/2020 4 CASAMENTO CHARLES J (Director) has filed a Form 4 on RELMADA THERAPEUTICS, INC.
Txns: Sold 3,000 shares @ $30.2879, valued at $90.9k
10/02/2020 4 CASAMENTO CHARLES J (Director) has filed a Form 4 on RELMADA THERAPEUTICS, INC.
Txns: Sold 3,000 shares @ $37.9852, valued at $114k
09/02/2020 4 CASAMENTO CHARLES J (Director) has filed a Form 4 on RELMADA THERAPEUTICS, INC.
Txns: Sold 3,000 shares @ $34.7356, valued at $104.2k
08/19/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/04/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/02/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/07/2020 4 CASAMENTO CHARLES J (Director) has filed a Form 4 on AzurRx BioPharma, Inc.
Txns: Granted 80,000 options @ $0.97, valued at $77.6k
03/23/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy